Chronic Myeloid Leukemia in Pregnancy: Implications for Treatment, Safety, and Fertility

While effective treatments, like tyrosine kinase inhibitors, have made CML a manageable chronic disease, managing CML in women who are pregnant or planning pregnancy remains challenging due to the need to balance disease control with maternal, fetal, and future fertility considerations. In this MEDtalk, Elisabetta Abruzzese, MD, PhD, discusses the associated clinical challenges and emerging data.